Mr. Frank YANG
- Founding Partner & CEO, Blue Ocean Capital Group
Mr. Frank Yang has over 20 years VC/PE experience with a record of multibillion-dollar investments in the pharmaceutical industry.
Prior to founding Blue Ocean Capital Group, Mr. Yang served as Managing Director at CCBI, responsible for principal investments and China’s first institutional healthcare PE fund. Mr. Yang led investments in dozens of pharmaceutical companies including Innorna, Cure Genetics, Koka Lifesciences, InterHill MED, HighTide Therapeutics, Boan Biotech, Ribo Life Sciences and Signet Therapeutics, among some of which he served as a board member.
Mr. Yang sits on the board of HK Bio-Med Innovation Association (“HKBMIA”), Chinese Financial Association in Hong Kong(“HCFA”), PRC Committee of Hong Kong Venture Capital and Private Equity Association (“HKVCA”), and the advisory board of HKUST MBA Business School. Mr. Yang is a PhD candidate of CUHK and holds the MBA degree from HKUST.